Comparing single vs multiple sessions of spine radiosurgery for spinal metastases
Official title: A Randomized Phase III TriaL Comparing SingLe- Versus Multi-Fraction Spine STereotActic Radiosurgery for Patients With Spinal Metastases (ALL-STAR)
Run by Stanford University · NCT06173401 · Data updated 2026-11-12
This study tests whether one session or two sessions of targeted radiation therapy can better control tumors in the spine for adults with metastatic cancer.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 274 (estimated) |
| Sponsor | Stanford University Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Palo Alto, California) |
| Status | Recruiting |
| Started | December 18, 2023 |
| Main results expected | December 2028 |
| Study ends | December 2028 |
| Registry record updated | July 27, 2026 |
| Trial ID | NCT06173401 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with confirmed metastatic cancer and 1 to 3 spinal sites needing treatment.
✕Probably not a fit
Patients with prior radiation treatment at the study site or those unable to undergo necessary imaging may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to evaluate the effectiveness of single-fraction versus multi-fraction stereotactic radiosurgery (SRS) in treating spinal metastases. Patients will be randomly assigned to receive either 22 Gy in one session or 28 Gy in two sessions of SRS. The study focuses on determining which approach leads to better local tumor control. Eligible participants include adults with confirmed metastatic cancer affecting the cervical, thoracic, or lumbar spine, requiring treatment at one to three spinal sites.
Why it matters
Potential benefit: If successful, this study could provide insights into optimizing treatment for spinal metastases, potentially improving patient outcomes.
How similar studies have gone: Previous studies have explored various approaches to radiosurgery, but this specific comparison of single vs multi-fraction SRS is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Histologically, cytologically, or radiographically confirmed diagnosis of metastatic cancer Age ≥ 18 years * Patients who have cervical, thoracic, or lumbar spine metastasis that need treatment. * Patients will have 1 to 3 separate spinal sites that require treatment. * Each spinal site to be treated on trial will span 1-2 contiguous vertebral levels * ECOG 0-2 * Negative serum or urine pregnancy test within 14 days prior to enrollment for people of childbearing potential or who are not postmenopausal * people of childbearing potential and male participants who are sexually active must agree to use a medically effective means of birth control * Ability to understand and the willingness to sign (personally or by a legal authorized representative) the written IRB approved informed consent document Exclusion Criteria: * Prior or planned radiation off study within or overlapping with study treatment site * Inability to have either an MRI or a CT scan. Patients with pacemaker will be allowed to undergo CT instead of MRI * Pediatric patients (age \<18 years old), pregnant women, and nursing patients will be excluded * Histology's of myeloma or lymphoma * Patients with strength 1-3 (of 5), bladder incontinence, bowel incontinence, and/or bladder retention that is associated with spinal site to be treated * Prior surgery to spinal site intended to be treated with protocol SRS * Excluded those with SINS 13-18
Where it's running
-
Stanford University School of Medicine
Palo Alto, California, United States Recruiting
Study contacts
- Principal investigator: Erqi Pollom, MD — Stanford University
- Study coordinator: Kelly Huang
- Email: kelhuang@stanford.edu
- Phone: 650-724-4606
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Stereotactic body radiation therapy for spinal metastases with epidural compression
This study tests whether SBRT can safely help adults with spinal metastases that compress the spinal cord see if the treatment works in reducing issues from their cancer.
-
Postoperative Edge SBRT for Spinal Metastases
This observational study tests whether high-precision postoperative SBRT with the Edge system can improve local control and neurological outcomes in patients with spinal metastases after surgery.
-
Radiotherapy after Separation Surgery for Spinal Metastases
This study tests whether giving radiotherapy after separation surgery helps people with spinal metastases live longer and feel better.
-
Focused high-dose SBRT for spinal tumors
This program will try focused high-dose SBRT for adults with spinal metastases to track side effects and local tumor control during routine care.
-
Pre-surgery focused radiation for spinal metastases.
This trial will test whether short-course, focused radiation given before surgery can improve local tumor control and reduce pain and disability in adults with spinal metastases.
-
Evaluating autologous blood transfusion in spinal surgery for lung cancer with spinal metastasis
This study is testing whether using a patient's own blood during spinal surgery for lung cancer with spinal metastases is safer and more effective than using donated blood.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.